Acute Demyelinating Relapse Management

Acute Demyelinating Relapse Management is a clinical intervention strategy within neuroinflammatory disorder pharmacotherapy that specifically addresses the rapid suppression of immune-mediated demyelination during acute relapses through targeted immunomodulatory or immunosuppressive therapies.

25

Publications

1.9K

Citations

176

Authors

87

Institutions

Publications per year

2017–2026

4

Authors

176

  1. ML
    Michael Levy

    Johns Hopkins University, United States

    2 publications · 255 citations

    2

    h-index

  2. AJ
    Alan J. Thompson

    University College London, United Kingdom

    2 publications · 320 citations

    2

    h-index

  3. AB
    Anat Biegon

    Weizmann Institute of Science, Israel

    1 publications · 79 citations

    1

    h-index

  4. WI
    W. I. McDonald

    University College London, United Kingdom

    1 publications · 191 citations

    1

    h-index

  5. RM
    Romain Marignier

    Hospices Civils de Lyon, France

    1 publications · 13 citations

    1

    h-index

1–5 of 176

Venues

  1. Neurology

    5 publications · 529 citations

    5

    h-index

  2. European Neurology

    2 publications · 101 citations

    2

    h-index

  3. Journal of Neuroimmunology

    JNI · 2 publications · 125 citations

    2

    h-index

  4. Journal of Neurology Neurosurgery & Psychiatry

    2 publications · 340 citations

    2

    h-index

  5. Journal of Neurology

    1 publications · 86 citations

    1

    h-index

1–5